Literature DB >> 33520816

Gender dependent differences in lipid metabolism in individuals with type 2 diabetes mellitus.

Abhijit A Ghadge1, Abhay M Harsulkar1, Arundhati G Diwan2, Aniket A Kuvalekar1.   

Abstract

AIM: The present study investigates gender dependent effects of insulin resistance on lipid profile and adipocytokines in individuals with diabetes receiving oral antidiabetic drugs (OADs). The aim was also to reveal the changes in the expression of genes involved in lipid metabolism and inflammation.
METHODS: Lipid profile, adipocytokine levels and homeostatic model assessment of insulin resistance (HOMA-IR) was assessed in 100 patients with diabetes (M = 43, F = 57) matched for age and gender with healthy individuals (M = 45, F = 55). The expression pattern of genes was analyzed by quantitative real time PCR.
RESULTS: Males consuming metformin with other drugs exhibited a positive association between HOMA-IR and cholesterol, triglyceride and very low density lipoprotein (VLDL). Females consuming only metformin and metformin with other drugs, showed a positive association of HOMA-IR with cholesterol and a negative association with adiponectin. In males and females with diabetes, a comparable expression of peroxisome proliferator activated receptor γ (PPARγ) while higher expression of sterol regulatory element binding protein 1 (SREBP1) was observed. Expression of fatty acid synthase (FAS), long chain acyl CoA Synthetases (ACSL), malonyl-CoA-acyl carrier protein transacylase (MCAT) and nuclear factor kappa β (NFkβ) was higher in men with diabetes than healthy males. Expression of tumor necrosis factor α (TNF-α) was higher in males and females with diabetes than respective healthy genders.
CONCLUSION: Insulin resistance adversely affects lipid profile, adipocytokines in males with type 2 diabetes. Expression of genes involved in lipid metabolism and inflammation is found to be undesirably and differentially altered in both the genders. © Springer Nature Switzerland AG 2020.

Entities:  

Keywords:  Adipocytokine; Insulin resistance; Lipid metabolism; Oral antidiabetic drugs; Type 2 diabetes

Year:  2020        PMID: 33520816      PMCID: PMC7843816          DOI: 10.1007/s40200-020-00589-y

Source DB:  PubMed          Journal:  J Diabetes Metab Disord        ISSN: 2251-6581


  68 in total

Review 1.  Use and abuse of HOMA modeling.

Authors:  Tara M Wallace; Jonathan C Levy; David R Matthews
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

2.  Human obesity and type 2 diabetes are associated with alterations in SREBP1 isoform expression that are reproduced ex vivo by tumor necrosis factor-alpha.

Authors:  Ciaran Sewter; Dirk Berger; Robert V Considine; Gema Medina; Justin Rochford; Theodore Ciaraldi; Robert Henry; Lynis Dohm; Jeffrey S Flier; Stephen O'Rahilly; Antonio J Vidal-Puig
Journal:  Diabetes       Date:  2002-04       Impact factor: 9.461

3.  High density lipoprotein (HDL) metabolism in noninsulin-dependent diabetes mellitus: measurement of HDL turnover using tritiated HDL.

Authors:  A Golay; L Zech; M Z Shi; Y A Chiou; G M Reaven; Y D Chen
Journal:  J Clin Endocrinol Metab       Date:  1987-09       Impact factor: 5.958

4.  The lymphocyte as a cellular model to study insights into the pathophysiology of diabetes and its complications.

Authors:  M Balasubramanyam; C Premanand; V Mohan
Journal:  Ann N Y Acad Sci       Date:  2002-04       Impact factor: 5.691

Review 5.  Gender-specific care of the patient with diabetes: review and recommendations.

Authors:  Marianne J Legato; Andrea Gelzer; Robin Goland; Susana A Ebner; Sabitha Rajan; Victor Villagra; Mark Kosowski
Journal:  Gend Med       Date:  2006-06

6.  Chronic suppression of acetyl-CoA carboxylase 1 in beta-cells impairs insulin secretion via inhibition of glucose rather than lipid metabolism.

Authors:  Sarah M Ronnebaum; Jamie W Joseph; Olga Ilkayeva; Shawn C Burgess; Danhong Lu; Thomas C Becker; A Dean Sherry; Christopher B Newgard
Journal:  J Biol Chem       Date:  2008-04-01       Impact factor: 5.157

7.  Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study.

Authors:  Jang-Young Kim; Song Vogue Ahn; Jin-Ha Yoon; Sang-Baek Koh; Junghan Yoon; Byung-Su Yoo; Seung-Hwan Lee; Jong-Ku Park; Kyung-Hoon Choe; Eliseo Guallar
Journal:  Diabetes Care       Date:  2012-12-28       Impact factor: 19.112

8.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2009-01       Impact factor: 19.112

9.  Mechanisms of obesity-induced inflammation and insulin resistance: insights into the emerging role of nutritional strategies.

Authors:  Maeve A McArdle; Orla M Finucane; Ruth M Connaughton; Aoibheann M McMorrow; Helen M Roche
Journal:  Front Endocrinol (Lausanne)       Date:  2013-05-10       Impact factor: 5.555

10.  Anti-inflammatory effect of rosiglitazone is not reflected in expression of NFkappaB-related genes in peripheral blood mononuclear cells of patients with type 2 diabetes mellitus.

Authors:  Marjolijn C E Bragt; Jogchum Plat; Marco Mensink; Patrick Schrauwen; Ronald P Mensink
Journal:  BMC Endocr Disord       Date:  2009-02-25       Impact factor: 2.763

View more
  1 in total

1.  Screening and Conjoint Analysis of Key lncRNAs for Milk Fat Metabolism in Dairy Cows.

Authors:  Tong Mu; Honghong Hu; Xiaofang Feng; Yanfen Ma; Ying Wang; Jiamin Liu; Baojun Yu; Wan Wen; Juan Zhang; Yaling Gu
Journal:  Front Genet       Date:  2022-02-03       Impact factor: 4.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.